The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Clinical trial NCT03651544 · COMPLETED

Trial details

NCT number: NCT03651544
Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza A Virus Infection Influenza A Influenza Epidemic Influenza H5N1

Start date: 2018-10-15
Primary completion: 2018-12-24
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.